Oxford-AstraZeneca Vaccine Shows Promise in Early Human Testing

Published July 20, 2020

A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen